Company
CrossBridge Bio
| Industry | biotechnology pioneering dual-payload antibody-drug conjugates (ADCs) as targeted cancer therapies |
|---|
Funding raised
| Company | Round | Date |
|---|---|---|
| CrossBridge Bio | Pre-Seed | 2024-11-05 |
Company
| Industry | biotechnology pioneering dual-payload antibody-drug conjugates (ADCs) as targeted cancer therapies |
|---|
| Company | Round | Date |
|---|---|---|
| CrossBridge Bio | Pre-Seed | 2024-11-05 |